Vanda Pharmaceuticals
VNDA
VNDA
187 hedge funds and large institutions have $819M invested in Vanda Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1% more call options, than puts
Call options by funds: $1.84M | Put options by funds: $1.82M
1.23% less ownership
Funds ownership: 100.66% → 99.43% (-1.2%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
187
Holding in Top 10
–
Calls
$1.84M
Puts
$1.82M
Top Buyers
| 1 | +$17.4M | |
| 2 | +$14.1M | |
| 3 | +$5.14M | |
| 4 |
BlackRock
New York
|
+$3.28M |
| 5 |
Citigroup
New York
|
+$2.65M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$9.47M | |
| 3 | -$6.59M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$4.59M |
| 5 |
Renaissance Technologies
New York
|
-$4.56M |